ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Accession Therapeutics Limited

Accession Therapeutics Limited is an active company incorporated on 15 December 2020 with the registered office located in Oxford, Oxfordshire. Accession Therapeutics Limited was registered 5 years ago.
Status
Active
Active since incorporation
Company No
13083685
Private limited company
Age
5 years
Incorporated 15 December 2020
Size
Large
Did not meet the 2-out-of-3 criteria for Medium size or smaller.
Confirmation
Submitted
Dated 14 December 2025 (8 days ago)
Next confirmation dated 14 December 2026
Due by 28 December 2026 (1 year remaining)
Last change occurred 6 days ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (9 months remaining)
Address
Building 7600c The Quorum, Alec Issigonis Way
Arc Oxford North
Oxford
OX4 2JZ
United Kingdom
Address changed on 6 Jul 2023 (2 years 5 months ago)
Previous address was Building 7600,the Quorum Alex Issigonis Way Arc Oxford North Oxford OX4 2JZ United Kingdom
Telephone
07880 787185
Email
Unreported
Website
Unreported
People
Officers
4
Shareholders
20
Controllers (PSC)
1
Director • Danish • Lives in UK • Born in Aug 1959
Director • British • Lives in UK • Born in Mar 1947
Director • Chinese • Lives in China • Born in Jun 1988
Director • British • Lives in UK • Born in Dec 1946
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Trocept Therapeutics Limited
Nicholas John Cross and Bent Karsten Jakobsen are mutual people.
Active
Unequal Ltd
Nicholas John Cross and Bent Karsten Jakobsen are mutual people.
Active
Coombe Castle Fine Wines Limited
Ian Michael Laing is a mutual person.
Active
Wardsend Ltd
Ian Michael Laing is a mutual person.
Active
Wardsend Fidentia Limited
Ian Michael Laing is a mutual person.
Active
Cresta Run Limited
Ian Michael Laing is a mutual person.
Active
Thomas White Oxford Limited
Ian Michael Laing is a mutual person.
Active
Etcembly Ltd
Nicholas John Cross is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£4.37M
Decreased by £8.52M (-66%)
Turnover
Unreported
Same as previous period
Employees
45
Increased by 5 (+13%)
Total Assets
£10.34M
Decreased by £6.78M (-40%)
Total Liabilities
-£1.52M
Increased by £644K (+73%)
Net Assets
£8.82M
Decreased by £7.42M (-46%)
Debt Ratio (%)
15%
Increased by 9.59% (+187%)
Latest Activity
Confirmation Submitted
6 Days Ago on 16 Dec 2025
Mr Ian Michael Laing Appointed
2 Months Ago on 23 Oct 2025
Hans Ivar Robinson Resigned
2 Months Ago on 22 Oct 2025
Full Accounts Submitted
2 Months Ago on 8 Oct 2025
Confirmation Submitted
11 Months Ago on 8 Jan 2025
Full Accounts Submitted
1 Year 3 Months Ago on 17 Sep 2024
Confirmation Submitted
1 Year 12 Months Ago on 28 Dec 2023
Full Accounts Submitted
2 Years 3 Months Ago on 4 Sep 2023
Registered Address Changed
2 Years 5 Months Ago on 6 Jul 2023
Notification of PSC Statement
2 Years 11 Months Ago on 12 Jan 2023
Get Credit Report
Discover Accession Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 14 December 2025 with updates
Submitted on 16 Dec 2025
Statement of capital following an allotment of shares on 18 November 2025
Submitted on 2 Dec 2025
Statement of capital following an allotment of shares on 2 December 2025
Submitted on 2 Dec 2025
Memorandum and Articles of Association
Submitted on 20 Nov 2025
Resolutions
Submitted on 20 Nov 2025
Termination of appointment of Hans Ivar Robinson as a director on 22 October 2025
Submitted on 30 Oct 2025
Appointment of Mr Ian Michael Laing as a director on 23 October 2025
Submitted on 30 Oct 2025
Total exemption full accounts made up to 31 December 2024
Submitted on 8 Oct 2025
Statement of capital following an allotment of shares on 16 July 2025
Submitted on 21 Jul 2025
Statement of capital following an allotment of shares on 2 April 2025
Submitted on 3 Apr 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year